Delaware.

2000-2006

In September 2002, its drug Iressa (gefitinib) was approved in Japan as monotherapy for non-small cell lung cancer. On 3 January 2004 Dr Robert Nolan, a former director of AstraZeneca, formed the management team of ZI Medical.

In December 2005, the company acquired KuDOS Pharmaceuticals, a UK biotech company, for £120 million. That same year, the firm also became a Diamond Member

1.Previous
3.Next